Skip to main content
. 2011 Oct 28;6(10):e26367. doi: 10.1371/journal.pone.0026367

Figure 5. Ki values of all peptides (including hirulog-1/bivalirudin).

Figure 5

Peptides are grouped according to their mechanism of actions. All competitive inhibitors (fast or slow) have higher affinities to thrombin compared to hirulog-1/bivalirudin. The most potent variant DV24K10RYsulf is about 70-fold stronger. Even their cleavage products (non-competitive inhibitors) are potent inhibitor, with one of them, MH18Ysulf, binds to thrombin approximately 2-fold tighter than hirulog-1/bivalirudin.